FindTrial
Sign In

Is MRI a useful tool in determining the end point of anti-tubercular therapy in treatment of Tuberculosis of the spine?

Is MRI a useful tool in determining the end point of anti-tubercular therapy in treatment of Tuberculosis of the spine? - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/082020
Enrollment
101
Registered
2025-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A180- Tuberculosis of bones and joints

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Adult patients diagnosed with Tuberculosis of spine with MRI done at 12 months. -Patients compliant to treatment(according to DOTS and NTEP guidelines)

Exclusion criteria

Exclusion criteria: -Patients not willing to participate in the study -Pregnant and lactating women -Immunocompromised

Design outcomes

Primary

MeasureTime frame
Visualization of active, resolving or resolved TB lesions of spine using MRITimepoint: 1 year—

Secondary

MeasureTime frame
MRI as a standard investigation to determine the stoppage of ATTTimepoint: Baseline & 1 year follow up—

Countries

India

Contacts

Public ContactDr Madhava Pai K

Kasturba Medical College and Hospital, Manipal

shyambhat.n@manipal.edu9480486075

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026